John Mac
Senior Member (Voting Rights)
My boldingKatharine Cheston discusses the isolation, disbelief and stigma experienced by people with poorly understood medical conditions
Autobiographical accounts of illness tend to follow a similar script. Typically, they open with an interruption: new symptoms render the normal abnormal, precluding what had previously been taken for granted. These symptoms are recounted to a healthcare professional: tests are ordered, examinations requested, referrals made – each producing pieces of a diagnostic puzzle to be slotted together by specialists.
Eventually, a diagnosis materialises, functioning both as the key that unlocks a treatment plan, as well as the lens through which the ill person – and, in turn, readers of their illness tale – makes sense of what is to come.
But what if this diagnostic puzzle is not solved? What happens when symptoms persist unabated – fevers continue to flare, pain still shoots and stabs – but tests repeatedly return normal results; when the body remains an opaque mystery, its disease and dysfunction invisible to presently-available medical science? What is it like to experience severe symptoms for which a distinct diagnostic biomarker cannot yet be found?
This situation is more common than one might expect – or, indeed, hope. It is thought that between 25-50% of all GP consultations ‘concern symptoms that are not medically explained’ (Verhaak 2006), while ‘a third of new referrals to specialist medical clinics’ will not result in the definitive diagnosis that patients and professionals alike so desire (Burton 2010).
Although most of these symptoms are transient, ‘approximately 2% of adults experience persistent or recurrent symptoms which are associated with increased primary care consulting and referral to secondary care’ (Morton 2017).
Diagnostic labels such as Medically Unexplained (Physical) Symptoms (MUS/MUPS) or Persistent Physical Symptoms (PPS) are often employed in these circumstances.
Alongside symptom-based categories, such as chronic back pain, these labels also encompass – controversially – symptom ‘clusters’ that include poorly-understood conditions such as irritable bowel syndrome and chronic fatigue syndrome, for which there are growing bodies of biomedical evidence (Saito 2011, Padhy 2015; Saha 2019, Mueller 2020, Sweetman 2019). Debates continue regarding the usefulness and appropriateness of these terms, but it is certainly clear that diagnostic labels such as MUS reveal nothing of the immense physical suffering that many with these diagnoses endure.
For example, it might be surprising for many to learn that successive studies have shown that, on average, patients with chronic fatigue syndrome experience a significantly lower quality of life and are more functionally impaired than patients with diseases such as cancer, heart disease, and multiple sclerosis (Hvidberg 2015, Nacul 2011, Komaroff 1996).
https://thepolyphony.org/2020/09/29/shame-stigma-and-unexplained-symptoms/